Mirum Pharmaceuticals (MIRM) Net Cash Flow (QoQ) (2019 - 2026)
Mirum Pharmaceuticals (MIRM) Net Cash Flow (QoQ) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Mirum Pharmaceuticals |
6.29 Bn |
5.90 Bn |
131.08 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
85.09% |
| Dec 31, 2025 |
-69.99% |
| Sep 30, 2025 |
279.01% |
| Jun 30, 2025 |
220.39% |
| Mar 31, 2025 |
-1,385.43% |
| Dec 31, 2024 |
108.96% |
| Sep 30, 2024 |
85.28% |
| Jun 30, 2024 |
-522.03% |
| Mar 31, 2024 |
197.41% |
| Dec 31, 2023 |
-374.02% |
| Sep 30, 2023 |
-95.85% |
| Jun 30, 2023 |
596.83% |
| Mar 31, 2023 |
370.73% |
| Dec 31, 2022 |
59.76% |
| Sep 30, 2022 |
-315.46% |
| Jun 30, 2022 |
-39.44% |
| Mar 31, 2022 |
-80.22% |
| Dec 31, 2021 |
309.15% |
| Sep 30, 2021 |
-2,969.16% |
| Jun 30, 2021 |
102.45% |
